Merit Medical Systems, Inc.

MMSI · NasdaqGS · Stock · Healthcare
$87.16
-1.11% today
Delayed price,

What Merit Medical Systems does

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

Key facts

Sector
Healthcare
Industry
Medical Instruments & Supplies
Market cap
$5.20B
P/E (ttm)
36.3
Forward P/E
18.9
Dividend yield
0.00%
Beta
0.51
Profit margin
9.2%
Employees
7,500
Headquarters
South Jordan, UT, United States
Exchange
NasdaqGS

Performance

1 Month
+2.1%
3 Months
+17.8%
6 Months
+22.9%
1 Year
+6.5%
5 Years
+38.7%
$59.7452-week range$94.75
Biggest setback — last 12 months
-30.1%
15 Dec 2025 → 4 May 2026
Fell from $87.70 to $61.27 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+48.2%
4 May 2026 → 17 Aug 2026
Ran from $61.27 to $90.78 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Above long-term trend
Price sits above its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$80.71 (-7.4%)$87.16$94.12 (+8.0%)
3 Months$76.30 (-12.5%)$87.16$99.57 (+14.2%)
6 Months$72.21 (-17.2%)$87.16$105.21 (+20.7%)
12 Months$66.79 (-23.4%)$87.16$113.74 (+30.5%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 26.6%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.